Studies have shown that increased survival of NSCLC patients with high FAP expression may be positively related to forkhead box protein 3 (FOXP3) cells, which are involved in the chemotaxis of immunosuppressive cells[68]. The gene discussed is FOXP3; the disease is non-small cell lung carcinoma.